Staphylococcus aureus infection primary prevention: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) Created page with "__NOTOC__ {{Staphylococcus aureus infection}} {{CMG}} ==References== {{reflist|2}} Category:Disease Category:Infectious diseases" |
Gerald Chi- (talk | contribs) mNo edit summary |
||
| Line 2: | Line 2: | ||
{{Staphylococcus aureus infection}} | {{Staphylococcus aureus infection}} | ||
{{CMG}} | {{CMG}} | ||
==Primary Prevention== | |||
===Antimicrobial Prophylaxis=== | |||
* '''Staphylococcus aureus, prophylaxis''' | |||
:* 1. '''Prophylaxis for coronary artery bypass graft-associated acute mediastinitis'''<ref name="pmid22070836">{{cite journal| author=Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG et al.| title=2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. | journal=J Am Coll Cardiol | year= 2011 | volume= 58 | issue= 24 | pages= e123-210 | pmid=22070836 | doi=10.1016/j.jacc.2011.08.009 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22070836 }} </ref> | |||
::* 1.1 '''Methicillin susceptible staphylococcus aureus (MSSA)''' | |||
:::* Preferred regimen: A first- or second-generation [[Cephalosporin]] is recommended for prophylaxis in patients without MRSA colonization. | |||
::* 1.2 '''Methicillin resistant staphylococcus aureus (MRSA)''' | |||
:::* Preferred regimen: [[Vancomycin]] alone or in combination with other antibiotics to achieve broader coverage is recommended for prophylaxis in patients with proven or suspected MRSA colonization | |||
:::* Note (1): Preoperative antibiotics should be administered to all patients to reduce the risk of mediastinitis in cardiac surgery. | |||
:::* Note (2): The use of intranasal [[Mupirocin]] is reasonable in nasal carriers of Staphylococcus aureus. | |||
==References== | ==References== | ||
| Line 8: | Line 21: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Infectious diseases]] | [[Category:Infectious diseases]] | ||
[[Category:Infectious Disease Project]] | |||
Revision as of 23:12, 7 August 2015
|
Staphylococcus aureus infection Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Primary Prevention
Antimicrobial Prophylaxis
- Staphylococcus aureus, prophylaxis
- 1. Prophylaxis for coronary artery bypass graft-associated acute mediastinitis[1]
- 1.1 Methicillin susceptible staphylococcus aureus (MSSA)
- Preferred regimen: A first- or second-generation Cephalosporin is recommended for prophylaxis in patients without MRSA colonization.
- 1.2 Methicillin resistant staphylococcus aureus (MRSA)
- Preferred regimen: Vancomycin alone or in combination with other antibiotics to achieve broader coverage is recommended for prophylaxis in patients with proven or suspected MRSA colonization
- Note (1): Preoperative antibiotics should be administered to all patients to reduce the risk of mediastinitis in cardiac surgery.
- Note (2): The use of intranasal Mupirocin is reasonable in nasal carriers of Staphylococcus aureus.
References
- ↑ Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG; et al. (2011). "2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons". J Am Coll Cardiol. 58 (24): e123–210. doi:10.1016/j.jacc.2011.08.009. PMID 22070836.